6 days CVS Health (NYSE:CVS) Upgraded by Barclays to “Overweight”MarketBeat
Barclays upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $63.00 to $82.00 in a research report on Thursday.
CVS Health Corp (CVS) · Health · NYSE · Science
X